Prognostic and clinical implication of a disintegrin and metalloprotease 8 expression in pediatric medulloblastoma

Journal of the Neurological Sciences

Volumn 323, Issue 1-2, 2012, Pages 46-51

  Zhang, Rongrong ^a   Yuan, Yufang ^a   Zuo, Jiandong ^b   Liu, Wenguang ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

A disintegrin and metalloprotease 8; Pediatric medulloblastoma; Prognosis

Indexed keywords

MESSENGER RNA; METALLOPROTEINASE; PROTEIN A DISINTEGRIN AND METALLOPROTEASE 8; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CEREBELLUM; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; UPREGULATION; WESTERN BLOTTING;

ADAM PROTEINS; CELL DIFFERENTIATION; CEREBELLAR NEOPLASMS; CEREBELLUM; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MEDULLOBLASTOMA; MEMBRANE PROTEINS; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; TREATMENT OUTCOME; UP-REGULATION;

EID: 84867866812     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.07.040     Document Type: Article

References (23)

1. J.F. Brasme, J. Grill, F. Doz, B. Lacour, D. Valteau-Couanet, and S. Gaillard Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome PLoS One 7 2012 e33415
2. R.E. Taylor, C.C. Bailey, K. Robinson, C.L. Weston, D. Ellison, and J. Ironside Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study J Clin Oncol 21 2003 1581 1591
3. C. Dufour, A. Beaugrand, B. Pizer, J. Micheli, M.S. Aubelle, and A. Fourcade Metastatic medulloblastoma in childhood: Chang's classification revisited Int J Surg Oncol 2012 2012 245385
4. U. Schlomann, S. Rathke-Hartlieb, S. Yamamoto, H. Jockusch, and J.W. Bartsch Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration J Neurosci 20 2000 7964 7971
5. A. Dijkstra, D.S. Postma, J.A. Noordhoek, M.E. Lodewijk, H.F. Kauffman, and N.H. ten Hacken Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung Virchows Arch 454 2009 441 449
6. S. Mochizuki, and Y. Okada ADAMs in cancer cell proliferation and progression Cancer Sci 98 2007 621 628
7. H. Ishizuka, V. García-Palacios, G. Lu, M.A. Subler, H. Zhang, and C.S. Boykin ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo J Bone Miner Res 26 2011 169 181
8. J.W. Bartsch, D. Wildeboer, G. Koller, S. Naus, A. Rittger, and M.L. Moss Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection J Neurosci 30 2010 12210 12218
9. T. Hall, L.E. Pegg, A.M. Pauley, H.D. Fischer, A.G. Tomasselli, and M.D. Zack ADAM8 substrate specificity: influence of pH on pre-processing and proteoglycan degradation Arch Biochem Biophys 491 2009 106 111
10. D. Wildeboer, S. Naus, Q.X. Amy Sang, J.W. Bartsch, and A. Pagenstecher Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness J Neuropathol Exp Neurol 65 2006 516 527
11. N.V. Valkovskaya Hypoxia-dependent expression of ADAM8 in human pancreatic cancer cell lines Exp Oncol 30 2008 129 132
12. I. Hernández, J.L. Moreno, C. Zandueta, L. Montuenga, and F. Lecanda Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer Oncogene 29 2010 3758 3769
13. F.R. Fritzsche, M. Jung, C. Xu, A. Rabien, H. Schicktanz, and C. Stephan ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis Virchows Arch 449 2006 628 636
14. V. Zielinski, M. Brunner, G. Heiduschka, S. Schneider, R. Seemann, and B. Erovic ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study BMC Cancer 12 2012 76
15. Z. Li, Q. Liao, Y. Wu, M. Liao, Y. Hao, and S. Zhang Upregulation of a Disintegrin and Metalloprotease 8 Influences Tumor Metastasis and Prognosis in Patients with Osteosarcoma Pathol Oncol Res 18 2012 657 661
16. S. He, L. Ding, Y. Cao, G. Li, J. Deng, and Y. Tu Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis Med Oncol 29 2012 2032 2037
17. D. Muzumdar, A. Deshpande, R. Kumar, A. Sharma, N. Goel, and N. Dange Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients J Pediatr Neurosci 6 2011 S78 S85
18. A. Varan Risk-adapted chemotherapy in childhood medulloblastoma Expert Rev Anticancer Ther 11 2011 771 780
19. T. Dehmel, A. Janke, H.P. Hartung, H.H. Goebel, H. Wiendl, and B.C. Kieseier The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies Neurobiol Dis 25 2007 665 674
20. M.L. Moss, and F.H. Rasmussen Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening Anal Biochem 366 2007 144 148
21. V.H. Guaiquil, S. Swendeman, W. Zhou, P. Guaiquil, G. Weskamp, and J.W. Bartsch ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice J Mol Med (Berl) 88 2010 497 505
22. N. Ishikawa, Y. Daigo, W. Yasui, K. Inai, H. Nishimura, and E. Tsuchiya ADAM8 as a novel serological and histochemical marker for lung cancer Clin Cancer Res 10 2004 8363 8370
23. N. Valkovskaya, H. Kayed, K. Felix, D. Hartmann, N.A. Giese, and S.P. Osinsky ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer J Cell Mol Med 11 2007 1162 1174